- Investing Ideas
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
AstraZeneca
Market Cap: UK£200.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£131.34
7D
3.4%
1Y
14.2%
hVIVO
Market Cap: UK£48.8m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.072
7D
7.4%
1Y
-27.5%